Chulalongkorn University’s COVID mRNA vaccine to enter human trials

Thailand’s Chulalongkorn University is seeking approval from the Thai Food and Drug Administration (TFDA) to begin the first two phases of human trials of its mRNA COVID-19 vaccine. According to…

Read More

Mass production of Thailand’s ChulaCov 19 mRNA vaccine expected early next year

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year, according…

Read More

฿3.6 billion approved for COVID-19 vaccine development

The Thai cabinet approved a 3.6-billion-baht fund on Thursday for the development and production of Thailand’s first two vaccines to fight COVID-19, which are now entering their third phase of…

Read More
Researcher prepare samples of human sweat for a Labrador Retriever, to detect the COVID-19 coronavirus at a mobile canine unit in Bangkok, Thailand. (AP Photo/Sakchai Lalit)

From nasal sprays to sniffer dogs: Thai researchers develop unique weapons to fight COVID-19

When Thailand began its battle against COVID-19 early last year, local scientists were quick to launch research programs on innovative weapons to contain the virus. So far, their hard work has…

Read More

Chula Uni recruiting 174 volunteers for human trials of its COVID-19 vaccine

Thailand’s Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development is recruiting 174 volunteers for human trials of its vaccine, known as ChulaCov19, scheduled to start at the end…

Read More

Human trials of first Thai developed COVID-19 vaccine begins Monday

Human trials of the first Thai COVID-19 vaccine, developed by Chula Vaccine Research Centre (CVRC) at Chulalongkorn University and King Chulalongkorn Memorial Hospital, began today (Monday). Called “ChulaCov19”, it is…

Read More

Page 1 of 1


Welcome! Login in to your account

Remember me Lost your password?

Lost Password